During the past decade, Azienda Sanitaria Universitaria Integrata di Udine conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 5 clinical trials were completed, i.e. on average, 12.2% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 4 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Sanitaria Universitaria Integrata di Udine" #1 sponsor was "Pfizer" with 4 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Azienda Ospedaliera Universitaria Integrata Verona" with 2 trials sponsored and "European Myeloma Network" with 2 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Sanitaria Universitaria Integrata di Udine" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 3 trials as a collaborator, "Agenzia Italiana del Farmaco" with 2 trials as a collaborator, "Azienda Sanitaria-Universitaria Integrata di Udine" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Sanitaria Universitaria Integrata di Udine" are "Multiple Myeloma" (4 trials), "COVID-19" (2 trials), "Hematologic Malignancies" (2 trials), "Melanoma" (2 trials) and "Myelofibrosis" (2 trials). Many other conditions were trialed in "Azienda Sanitaria Universitaria Integrata di Udine" in a lesser frequency.

Most popular intervention types in "Azienda Sanitaria Universitaria Integrata di Udine" are "Drug" (34 trials), "Other" (5 trials), "Device" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "No Intervention" (2 trials), "Sotrovimab" (2 trials), "parsaclisib" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Sanitaria Universitaria Integrata di Udine" are 45 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are 23 active trials in "Azienda Sanitaria Universitaria Integrata di Udine". 1 are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Azienda Sanitaria Universitaria Integrata di Udine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Sanitaria Universitaria Integrata di Udine, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".